{"as_of":"2026-08-15T19:37:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:1312070f6461d00c2bef1d0af378b99504d4725d7305abf552ef884a43cdc550","coverage":[{"denominator":300,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":100,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-06T20:14:36.484419Z","state":"measured"},{"denominator":100,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":100,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-15T06:32:42.880941+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2507.03407/citation-record","integrity":"/paper/2507.03407/integrity","json":"/paper/2507.03407/citation-record.json","paper":"/paper/2507.03407"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.465974Z","title":"Nature Reviews Drug Discovery, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.465974Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:cb13db677805d10ef9b243e1e6bc89bd9946a1f61a8d8849e8b272c71e517924","observation_id":"1ad8d444-0b93-4370-b2ec-9c16e27e1e8f","resolution":{"observed_at":"2026-08-06T20:14:35.465974Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.515634Z","title":"Molecular Therapy Nucleic Acids, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.515634Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e6e70fdd605df9b140374c522bf53243f95425ae1b86212432c9e9dd37a5f7fd","observation_id":"114ccddb-e6e4-412f-9ef2-dc9b92a1280a","resolution":{"observed_at":"2026-08-06T20:14:35.515634Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.586796Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.586796Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:221b86b72110c6bb2341233a069fcad34195fdbabf837a8c5afcb621815fd04b","observation_id":"8f2b8b1a-5405-494d-a5e3-78a5d36bec55","resolution":{"observed_at":"2026-08-06T20:14:35.586796Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.664584Z","title":"Briefings in Bioinformatics, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.664584Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:da4ec509df67e93463c5e1fc1c2187e3bbe43ff0d0f4a7492c1a6ad4745697be","observation_id":"f4c78146-14db-4c06-9e22-efd41dd41784","resolution":{"observed_at":"2026-08-06T20:14:35.664584Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.720266Z","title":"Pharmaceuticals, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.720266Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:65e80c2d881ade7d223753f45b92c8bf3d183cc49a5aede8a6869e00a195d865","observation_id":"7bd1b908-30f3-4d97-8c60-88f369776624","resolution":{"observed_at":"2026-08-06T20:14:35.720266Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.786669Z","title":"Expert Opinion on Drug Discovery, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.786669Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:c10c3488a0ed9f729d3588660dc8521190c66010d0d65cf614e9d07f38194ab6","observation_id":"6e1b797c-fbb1-421e-b634-08c7451d6909","resolution":{"observed_at":"2026-08-06T20:14:35.786669Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.861302Z","title":"European Journal of Pharmaceutical Sciences, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.861302Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:249d3f5c66fd1b409c059b783d1342e4c96cf231955f7ded9cadd2e070aaf263","observation_id":"dad5ae6e-f7e7-484a-a828-65c9ebbe76a9","resolution":{"observed_at":"2026-08-06T20:14:35.861302Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.930971Z","title":"Artificial Intelligence Review, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.930971Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f2b6e946eda6e636b9b63f7e2c098d4dc46293d7165d666d547da24be14a7d5c","observation_id":"ddc50ccb-5dec-4021-857a-a9c3dafa3f26","resolution":{"observed_at":"2026-08-06T20:14:35.930971Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:35.938957Z","title":"Jama Psychiatry, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:35.938957Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a280ba385d92efaf545ac879d2a030aa2db24129f23a5648d3200eb846a6dc40","observation_id":"ab12c733-0872-4e9e-9632-24752fe8b1f3","resolution":{"observed_at":"2026-08-06T20:14:35.938957Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.059671Z","title":"Pharmaceutics, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.059671Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a8b4c10ee1381228bbe2666bc6d0269222749df5aa6c92beb5a5eb85a82409ce","observation_id":"a8bd6c04-8fee-4c93-9daa-eae8cb52d86f","resolution":{"observed_at":"2026-08-06T20:14:36.059671Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.156905Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.156905Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f41023071ca92097a3d6b93a3694e67c5f4b717672c76c793c914342684e7f1e","observation_id":"9079e92a-8417-4f52-8626-c0fadfeddec4","resolution":{"observed_at":"2026-08-06T20:14:36.156905Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.177421Z","title":"Computational and Structural Biotechnology Journal, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.177421Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e15bc7e90e4da749ec3fb80a5c753d064282286299b5180cae0e7416b9e073a1","observation_id":"8198b0f1-1503-4eba-a9b0-3d30e6c29ab1","resolution":{"observed_at":"2026-08-06T20:14:36.177421Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.182125Z","title":"International Journal of Molecular Sciences, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.182125Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2057ad2ef1c7816b22bded0118d246e9afe84cd820c4f0ad3663943550b84900","observation_id":"1bc03f8c-2011-43f7-a05c-6f9ba78589c2","resolution":{"observed_at":"2026-08-06T20:14:36.182125Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.185727Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.185727Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6ec469eab81ece33bcea5150ca578a155fb4a7cdd412efbc23c36b5e35ebc86b","observation_id":"80a93a8c-4672-4c62-beec-dad70e5f9da7","resolution":{"observed_at":"2026-08-06T20:14:36.185727Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.190158Z","title":"Medicinal Research Reviews, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.190158Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b39c77998edaa910340cbf08870d86fd5d3109f9bed1f2bc7b579203d13f79a6","observation_id":"512c6d2f-6018-4546-8e48-3e35ea363e0b","resolution":{"observed_at":"2026-08-06T20:14:36.190158Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.193994Z","title":"Artificial Intelligence Review, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.193994Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8f7fd9f85e701843f82e8be6c8b428e123e53e05d14caf4aa7cd801a3e76eb60","observation_id":"fb84ec2a-ac9a-4f7e-ba80-74756457937e","resolution":{"observed_at":"2026-08-06T20:14:36.193994Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.197938Z","title":null,"venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.197938Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:67ea39bdfeb4b660a77771d7735cb3c8ac63633e233b1ca0a8f0a9c177d30fda","observation_id":"0f888cf1-d890-4a38-85b2-b8df686cccb0","resolution":{"observed_at":"2026-08-06T20:14:36.197938Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.202012Z","title":"Nature Reviews Drug Discovery, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.202012Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:be89a71f5cdcc580e5f73fa92192d2603f2a821e08ecebb995e4dfdd5a007467","observation_id":"fdc1ffde-fbf3-4937-86e0-fcba1027a234","resolution":{"observed_at":"2026-08-06T20:14:36.202012Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.205374Z","title":"20(2): p","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.205374Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:d3b4e77b4918c0b04f3473795bed761b8673f758c4dc4ea89f56f4815eb58215","observation_id":"cadc2525-d759-4d52-84c7-1cc9f084ce1d","resolution":{"observed_at":"2026-08-06T20:14:36.205374Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.208903Z","title":"Insel, Editor","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.208903Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8c81cc3b333eab32cc45332b076dbf1fb5df1c7a0e7b02076dd9b3a1e45e1137","observation_id":"4979eeab-69ec-4519-9b09-9b295e30d2ac","resolution":{"observed_at":"2026-08-06T20:14:36.208903Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.212365Z","title":null,"venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.212365Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:08e4ce9de197ea23b241b3b78f33069df7bd28ad3ca68a5afa6fdcc5878b8d20","observation_id":"d7fc43a7-ea86-454c-98b1-925ee38111fa","resolution":{"observed_at":"2026-08-06T20:14:36.212365Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.216724Z","title":"Grisoni, and G","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.216724Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:0aa5b914ae5874afdd697dfedc16f23731d991e56dcf47306c1cb40a20b3ea08","observation_id":"c8164146-ea4d-4581-8190-0e3a3419211e","resolution":{"observed_at":"2026-08-06T20:14:36.216724Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.221642Z","title":"Expert Opinion on Drug Discovery, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.221642Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f29e0651b9f77b882321f77cc5ab9a429bab930e83fac526c7edf70762a86358","observation_id":"b518cb0b-82fb-4b07-9ad3-5b47cbf5d9b9","resolution":{"observed_at":"2026-08-06T20:14:36.221642Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.225280Z","title":"Pharmaceuticals, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.225280Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e53cced5769f3edde2be5f5ccf6885767fed5909d1577ce59fd1671940e2681c","observation_id":"a0dc7c3b-bc43-4787-92bb-7a416a79e2b3","resolution":{"observed_at":"2026-08-06T20:14:36.225280Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.229031Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.229031Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:551ff8749a131c34c44e538ad9636d2781e819bcd19b7639ca97b7e5f0ca35fd","observation_id":"0e6d80f9-2a7d-47d9-b109-1457f93dbcdb","resolution":{"observed_at":"2026-08-06T20:14:36.229031Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.232908Z","title":"Scientific Reports, 2025","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.232908Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:212f3d3df59d5105c60962d8b234a6c1ff19dd13b9fa01f09902e406a997e924","observation_id":"93eb8ec4-c327-40f3-b98c-b086aea9829f","resolution":{"observed_at":"2026-08-06T20:14:36.232908Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.236872Z","title":"Scientific Reports, 2024","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.236872Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b50e82e005ebe22edf2331050efa1e4834fd8ecb5a4c93e904b610bfa704a2c2","observation_id":"b985011b-5f9b-4478-a68b-ee13eafcdb19","resolution":{"observed_at":"2026-08-06T20:14:36.236872Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.240344Z","title":"Frontiers in Medicine, 2025","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.240344Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f5b5ec16f905a8a5f08570a476e0ff7f7dca0900f733952d98f8157e32eeb157","observation_id":"4e837670-95a9-4626-8a96-384fae2b3cf9","resolution":{"observed_at":"2026-08-06T20:14:36.240344Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.243876Z","title":"European Journal of Clinical Investigation, 37","venue":null,"work_id":null,"year":1990},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.243876Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:25d3d0c05ccc278e54c66e37813e3ecf03c0150ebc0e74340a75a795e9bc077c","observation_id":"c5d8546d-b201-4f86-ac9f-23c81904f026","resolution":{"observed_at":"2026-08-06T20:14:36.243876Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.247386Z","title":"Nature chemical biology, 2013","venue":null,"work_id":null,"year":2013},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.247386Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b991da726ddedab35cdae0dff7ce33ec87820ddfbe2e10ab235c8882f7a34f2d","observation_id":"82a7f244-1fb9-4af5-ba89-ca13829727a2","resolution":{"observed_at":"2026-08-06T20:14:36.247386Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.251284Z","title":null,"venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.251284Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:84bf87c375e2b6b05ff44c664b2cb44ae62f4996f84163d0cf1db6bd66aa21bb","observation_id":"868f470c-84f1-48be-9e4a-8124a596cc39","resolution":{"observed_at":"2026-08-06T20:14:36.251284Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.254901Z","title":"Nature reviews Drug discovery, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":32,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.254901Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e567ed3f68b516139cc4050efb1b0e5ee7dc91a0d48a3c8e1331f22c4ebebc0d","observation_id":"2d0107cb-8015-4713-a46d-3e3904973264","resolution":{"observed_at":"2026-08-06T20:14:36.254901Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.259042Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.259042Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:83d37498aafca002880c9ccd13302d8adb985d9975e7060075909e6347760405","observation_id":"9fe4f64c-219f-46e7-9738-9d8562840e93","resolution":{"observed_at":"2026-08-06T20:14:36.259042Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.262941Z","title":"Data Science and Management, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.262941Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:cc01dd0d0906a368c723b9eb02ff715cc08b374ba7c61f8a6b7dda0dd9b92233","observation_id":"161c4855-4e6e-41f3-a97b-0e7150975160","resolution":{"observed_at":"2026-08-06T20:14:36.262941Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.267077Z","title":"Briefings in Bioinformatics, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.267077Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2e9b5c9cf4d124fc382e9081642c6d0c1c44604e86d0e607a2e38bbf5e4cb633","observation_id":"550397b9-9c91-4369-a332-b8cc89dc8fb9","resolution":{"observed_at":"2026-08-06T20:14:36.267077Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.270375Z","title":null,"venue":null,"work_id":null,"year":2014},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.270375Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:00957c9108ccff2b7fc3b22dfc66eb9176cafc1a7542b75794555673db2eaced","observation_id":"75fe2565-d42b-4475-ba62-685665a30f8f","resolution":{"observed_at":"2026-08-06T20:14:36.270375Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.273563Z","title":"Database, 2016","venue":null,"work_id":null,"year":2016},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.273563Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:0697086486ae0fa5bb84cdc3589b82bcf3456b4308833fb09514b8ebe766eba5","observation_id":"410f50d3-66b7-4fdf-aae9-39d5c47ffe72","resolution":{"observed_at":"2026-08-06T20:14:36.273563Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.276706Z","title":"Nucleic acids research, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.276706Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2be2c50f4f172bffced15008bccf6a8953214361bd54049ea2381afe799ded97","observation_id":"013b9128-cb1c-4033-bc6c-47a3e3b6028b","resolution":{"observed_at":"2026-08-06T20:14:36.276706Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2501.16255","last_updated":"2025-01-27T17:55:37Z","snapshot_observed_at":"2026-08-10T13:34:08.537518Z","submitted_at":"2025-01-27T17:55:37Z","title":"A foundation model for human-AI collaboration in medical literature mining","version":1},"cited_work":{"arxiv_id":"2501.16255","doi":null,"metadata_source":"pith","pith_arxiv_id":"2501.16255","snapshot_observed_at":"2026-08-06T20:14:37.202458Z","title":"A foundation model for human-AI collaboration in medical literature mining","venue":"cs.CL","work_id":"286b6b3e-539a-4245-bd43-733787c17140","year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":39,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.279769Z"},"links":{"cited_paper":"/paper/2501.16255","citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a107be62b939000f5a42dbc0663d3b37346a0dc3b14680e348f20c20e2f7b95d","observation_id":"ce21d88c-3a36-4214-b589-ef0eb0588ed4","resolution":{"observed_at":"2026-08-06T20:14:37.206079Z","resolver_source":"local_arxiv","status":"metadata_mismatch"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-15T06:32:42.880941+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-15T06:32:42.880941+00:00","source":"crossref"},{"observed_at":"2026-08-15T06:32:39.529945+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.284108Z","title":"European Journal of Technology, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":40,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.284108Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:54f03ba54762f933531477e3ca1b538921f35e59924a46769bf96ad39ff82250","observation_id":"3ebe714b-486a-4de5-b201-eed4e12ffa68","resolution":{"observed_at":"2026-08-06T20:14:36.284108Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.287735Z","title":"BMC bioinformatics, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":41,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.287735Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:03051b2def36029f93fe62381157a0446a6889fb73aa5792a055c011edfca578","observation_id":"3a4e6adc-bc59-4a67-87ad-aa5942fd1100","resolution":{"observed_at":"2026-08-06T20:14:36.287735Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.291530Z","title":"Nature communications,","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":42,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.291530Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:d17d93135a75d0f2b18c0dff962756a8215df8c82a6b1e4e3f5d31bb56b4df30","observation_id":"60b84165-be5e-475e-ad47-c7d4060c0cf3","resolution":{"observed_at":"2026-08-06T20:14:36.291530Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.294841Z","title":"PeerJ, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":43,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.294841Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:929e0aa820cfc3526e29d45fcd83bb274009a0f5b847b5a1683952c201f6776d","observation_id":"575624f5-6e0b-4331-8809-d25f1fefc4ab","resolution":{"observed_at":"2026-08-06T20:14:36.294841Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.297931Z","title":"Frontiers in Artificial Intelligence, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":44,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.297931Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:12be4d9e4a87ffd7767337f2a9c9e0b34a194a9bafff1b45340f4b72151ee38d","observation_id":"578bed97-13d0-4e9c-97af-dae93a82135d","resolution":{"observed_at":"2026-08-06T20:14:36.297931Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.300973Z","title":"Frontiers in pharmacology, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":45,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.300973Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:d2696ce33bc44cc4db43918467ea13dcad863002520c8a5c972cb1e0099c9c0b","observation_id":"20acabe7-3411-4f60-a2da-9f01455084d8","resolution":{"observed_at":"2026-08-06T20:14:36.300973Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.304402Z","title":"Scientific reports, 2020","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":46,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.304402Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:4b6aeb36ed7763665904b6ca4ca298c532199999f0045869accf55044a382fad","observation_id":"8c704e7c-816d-4f47-a7e2-d08338cb763c","resolution":{"observed_at":"2026-08-06T20:14:36.304402Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.307524Z","title":"Nature Biotechnology, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":47,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.307524Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:3cd2ffee683f11179fcd712130c07862a52650d301d6c332aacead9ddde57a43","observation_id":"d453bb6a-4476-4982-9dfd-e798ecd70888","resolution":{"observed_at":"2026-08-06T20:14:36.307524Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.310690Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":48,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.310690Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:c8a7939d090cd136a87ff285a533c55d23fca455207f9b6618c08a36fd0c0df6","observation_id":"9f3de34a-a1b9-4a51-bf57-814fa3223b47","resolution":{"observed_at":"2026-08-06T20:14:36.310690Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.313867Z","title":"Gene \\& Protein in Disease, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":49,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.313867Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:5f903136ab735c3e15be4cb0cceb14a7896890392cf0d4b3169bf5cb1f169dd4","observation_id":"db230fd8-2a22-486f-83f1-2d43d3aa3ca0","resolution":{"observed_at":"2026-08-06T20:14:36.313867Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.317098Z","title":"Suratanee, and K","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":50,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.317098Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e29986ab481dcb81b50099081c477c28ffeb5eaf764af2da3145e626ba86762f","observation_id":"6a67e185-df89-450f-afef-c1e3ee1f5162","resolution":{"observed_at":"2026-08-06T20:14:36.317098Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.320365Z","title":"Ghosh, and V","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":51,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.320365Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:996ecb8b6adaf36ed5a23d8e8512bd85341656fcdce5d41cfd237bc1339d164d","observation_id":"aa5450bd-dad6-4af4-b7f0-3137741043d5","resolution":{"observed_at":"2026-08-06T20:14:36.320365Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.323573Z","title":"Gulbahce, and J","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":52,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.323573Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:873a341872822be23a10edb8ca952c4960ff60a273ef332d85a756664bd544a3","observation_id":"71b87c24-5a9d-49fb-8759-10b83ed084d7","resolution":{"observed_at":"2026-08-06T20:14:36.323573Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.326927Z","title":null,"venue":null,"work_id":null,"year":2012},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":53,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.326927Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b0cd653b61c28c2ce5f41c4868b906dd1bc7e652f8f6a7d929cc14bfd1250f4d","observation_id":"670a0f13-d76d-4894-b67f-1136c2677b4c","resolution":{"observed_at":"2026-08-06T20:14:36.326927Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.330950Z","title":"IEEE Access, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":54,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.330950Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6561f5501964adde95c6959a6caf7ffe89b3e60fdccb7817066122846238b717","observation_id":"2de9fcc9-022f-4286-a62e-3be24ceaeb19","resolution":{"observed_at":"2026-08-06T20:14:36.330950Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.334616Z","title":"Bioinformatics, 2019","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":55,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.334616Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:31afdaeaed0f580ab575b51156cd75d3e548b50037aeaf571d46dff021238919","observation_id":"a16b966b-4c59-442e-bd61-80f5faa530c1","resolution":{"observed_at":"2026-08-06T20:14:36.334616Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.337787Z","title":"Briefings in bioinformatics, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":56,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.337787Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:5c23c44e3af1459e80c5ee130f25682efcdb2d1d48e6c34a9dcc5e089b893006","observation_id":"49507e3f-9a42-4ada-91c5-e153b4d38495","resolution":{"observed_at":"2026-08-06T20:14:36.337787Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.341008Z","title":"Chemical Science, 2020","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":57,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.341008Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a9a799406a63680ff4a5d2d2e42bc26be077e1531a3c6c24d88e3e19cf42e200","observation_id":"c5a45d2f-d6d2-4890-9587-bdd6b4321605","resolution":{"observed_at":"2026-08-06T20:14:36.341008Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.344535Z","title":"Thafar, and M","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":58,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.344535Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e51ebbeb058ceb0538e71fbd237ce062ffae6dcb914147a578f0c73b129ce6d4","observation_id":"1aece128-ed38-4ba2-8198-84a1ac021d31","resolution":{"observed_at":"2026-08-06T20:14:36.344535Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.347996Z","title":"International Journal of Quantum Chemistry, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":59,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.347996Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:389f762e108789681c3380eb7a2e89d9bf045d7ee6c53b987f6c6f5a641ab7f9","observation_id":"261a50da-6aea-45de-90fc-73b46feaaca0","resolution":{"observed_at":"2026-08-06T20:14:36.347996Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.351292Z","title":"Nature Machine Intelligence, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":60,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.351292Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:fabcd7a55cae8017425810c2c56297c6316d6a1a0fe8b993585576c4541e2804","observation_id":"794a9378-f72d-4e58-b3fb-0341a5208061","resolution":{"observed_at":"2026-08-06T20:14:36.351292Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.354750Z","title":"Nature communications, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":61,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.354750Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:e0b39b81725dd4f87634ee6a6b3d7ac2ffe7bc95fd44924bcea00ec96ed3bd67","observation_id":"268db3f6-a8a8-4f17-a7ce-ecba8db8fe16","resolution":{"observed_at":"2026-08-06T20:14:36.354750Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.358387Z","title":null,"venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":62,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.358387Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:45e994cdd9f860b44a37eb31e9fd28e04a9e076c553d4e155fa6cddba251f845","observation_id":"97521237-4797-4621-8ca6-c35a73529e5e","resolution":{"observed_at":"2026-08-06T20:14:36.358387Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.361755Z","title":"Nature reviews Drug discovery, 2003","venue":null,"work_id":null,"year":2003},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":63,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.361755Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:c9e33ded9079d801c462d8684f1b558a19ccfb25c03615578118e21094f79c04","observation_id":"c915eadb-95d1-4d46-9ac7-04ada7ca9101","resolution":{"observed_at":"2026-08-06T20:14:36.361755Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.365647Z","title":"Combinatorial chemistry \\& high throughput screening, 2003","venue":null,"work_id":null,"year":2003},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":64,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.365647Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:14260b93b359f112f7d042021ffd6a562b6f74dce00913ffee740d3d78da1fa1","observation_id":"497a1138-2837-4438-b757-b186413f3372","resolution":{"observed_at":"2026-08-06T20:14:36.365647Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.369296Z","title":"Onwuli, and A","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":65,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.369296Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:9120ea99cfc112544fd0fa5962f2e5005dbdbb8c345fb85480a703d8b06c315b","observation_id":"b0a06dd3-85fd-4fb0-b199-6e81fb2b731c","resolution":{"observed_at":"2026-08-06T20:14:36.369296Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.373348Z","title":"npj Drug Discovery, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":66,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.373348Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:4e615a8a3dbec0c9cdb0517673479f2aa2120729cb0147f7934a8cf74e5940af","observation_id":"1fa4202c-8eaf-4477-b943-b7b8cfb318d3","resolution":{"observed_at":"2026-08-06T20:14:36.373348Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.376597Z","title":"Trends in Chemistry, 2021","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":67,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.376597Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:10dfda71561cc82b18cdc2ad94da84f8b36879f45ad61ab763dc377fa0e851a7","observation_id":"24b4c54f-7aff-482b-b597-2622d6f18227","resolution":{"observed_at":"2026-08-06T20:14:36.376597Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.379778Z","title":"Current opinion in chemical biology, 2007","venue":null,"work_id":null,"year":2007},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":68,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.379778Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2e61e7085044b31497b9dc9ed61143dd0a2f1f482f47c3632ebac0400ef8d4b6","observation_id":"bfc7053d-f929-45cb-8a09-334ef978246d","resolution":{"observed_at":"2026-08-06T20:14:36.379778Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.382728Z","title":"Journal of chemical information and modeling, 2012","venue":null,"work_id":null,"year":2012},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":69,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.382728Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:4d452fed232b111ad8250fdc6b0eeae3f77e67cdb4971f83f2768cb10d22a87d","observation_id":"1a9cc169-92cf-4db7-ab3b-56b73a4c4e7e","resolution":{"observed_at":"2026-08-06T20:14:36.382728Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.385871Z","title":"Journal of medicinal chemistry, 2010","venue":null,"work_id":null,"year":2010},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":70,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.385871Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2f689cf7511874278b96d31d7bfe29dcae4264863d5eff2d16a41b301801e9a4","observation_id":"c120821d-909c-484b-940b-d2ec3e51a361","resolution":{"observed_at":"2026-08-06T20:14:36.385871Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.388946Z","title":"European Journal of Medicinal Chemistry, 2024: p","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":71,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.388946Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:1fd10547334c02fac02aa60d5ec57ae64b6bbcd6b74bdb72434eabd6323e9277","observation_id":"dc31b134-5bce-4c64-8f6f-6e2d5da0f10a","resolution":{"observed_at":"2026-08-06T20:14:36.388946Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.392211Z","title":"Nature Communications, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":72,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.392211Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ef617568b3be9a78a251720a536a84aa8b5bf125f2b3533ed86b05c5221d8f54","observation_id":"fdf1518b-f1e5-4116-b3b1-2a21387e9df4","resolution":{"observed_at":"2026-08-06T20:14:36.392211Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.395465Z","title":"Nature Communications, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":73,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.395465Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2cdc1e2dc587668ff1c5a32bce0321f7fdb5e641bb7d4b0e56e49a88e2127f82","observation_id":"f6aa335f-3d4d-4936-b090-40cd00fa937c","resolution":{"observed_at":"2026-08-06T20:14:36.395465Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.398787Z","title":"Signal Transduction and Targeted Therapy, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":74,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.398787Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8802e3213d36d4644e730f8ece886148d9913e425e3c96a768617eb609f46196","observation_id":"4641c422-d092-44ae-9608-35ffd573e132","resolution":{"observed_at":"2026-08-06T20:14:36.398787Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.402713Z","title":"Beni -Suef University Journal of Basic and Applied Sciences, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":75,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.402713Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:36fa294ee93bf1598ed415d331e30bd153a11d513155c3d37495a49219b1f3ca","observation_id":"ac207edf-edf4-481e-8fc3-92fa94264e5f","resolution":{"observed_at":"2026-08-06T20:14:36.402713Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.406183Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":76,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.406183Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:eab9262babf4bd4cb161f467224b60e0a91e1873d146c58122a7dcb69327f315","observation_id":"93f3d750-be24-4fb6-8fed-f84fc2656991","resolution":{"observed_at":"2026-08-06T20:14:36.406183Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.409157Z","title":null,"venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":77,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.409157Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:74ec731b7e0862d0bfc406adc63786d58e430ae9e9c2a63ff648447983d7a015","observation_id":"f0d2dcc3-26c1-4c23-bea5-876d5ed8b56e","resolution":{"observed_at":"2026-08-06T20:14:36.409157Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.412110Z","title":"Briefings in Bioinformatics, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":78,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.412110Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:425b989daf35617f41eff993c88d3109e01c9de37ea6cbec3d31042045055de7","observation_id":"ae22081f-37d3-4345-84de-08b0ba2524a0","resolution":{"observed_at":"2026-08-06T20:14:36.412110Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.414810Z","title":null,"venue":null,"work_id":null,"year":2010},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":79,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.414810Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:91c945e8ecf3bb6454d14984957942a687c795071850e7df3a7799ec72a9fd88","observation_id":"d0299c87-03a8-450a-bd44-e99385c9a656","resolution":{"observed_at":"2026-08-06T20:14:36.414810Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.417690Z","title":"BMC bioinformatics, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":80,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.417690Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:187a46eb28a06e9e6caf97c76555e29e6f99a0fa7a9fb1cd4b801228ead18df1","observation_id":"21db8aa0-338f-4f36-b890-05223e89cd2b","resolution":{"observed_at":"2026-08-06T20:14:36.417690Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.420648Z","title":"Communications Chemistry,","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":81,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.420648Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:2117143e35c4c7548b8c8012463c65e86c6a5e36bd205516fc864c067ccdedb2","observation_id":"57cbb3e7-205d-4412-b379-5e303a40457d","resolution":{"observed_at":"2026-08-06T20:14:36.420648Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.424791Z","title":"Morris, and P.C","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":82,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.424791Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b057d7a28d92b7dd8ba3cbfc29c624323c10f4a271c24a34975548e81340815d","observation_id":"9ce2d5b5-c0ba-4756-a1d3-df0a024ccea5","resolution":{"observed_at":"2026-08-06T20:14:36.424791Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.428605Z","title":"Junaid, and W","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":83,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.428605Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:63a1916a480d965170c3967b30fe0e7a70f161a4b0f039bdb547c85e3e8faeb7","observation_id":"5cfb421c-5cf3-466a-809f-80e6971ed680","resolution":{"observed_at":"2026-08-06T20:14:36.428605Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.431641Z","title":"Sivula, and A","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":84,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.431641Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b2eedf51cdc58de50dea133c40f78d950d4e0a4407fd83b57bedbd99761021a2","observation_id":"35fd26cb-2e06-4cc0-b3a0-cb2ccc9fe13c","resolution":{"observed_at":"2026-08-06T20:14:36.431641Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.436205Z","title":"Nam, and S","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":85,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.436205Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:6e30deadbc39e11dc29667a32e17c09309222531cddf11df97ee2b9540370d38","observation_id":"2696b7d0-34dd-48b3-b6a7-e12249a01964","resolution":{"observed_at":"2026-08-06T20:14:36.436205Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.439222Z","title":"Nature Protocols, 2022","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":86,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.439222Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:b6963be39017911f519864b8923361455a6bd02b7f6546eb358fd6acc84cf949","observation_id":"13ef8a4a-f18e-413c-974f-68b449d7b833","resolution":{"observed_at":"2026-08-06T20:14:36.439222Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.442456Z","title":"Nature Computational Science, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":87,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.442456Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:489f3ae8ab20902b20139608487b9f5d38db7065d1ef5643e453b113570055e2","observation_id":"6b76caa7-17a4-4ad8-992e-511bc2ee11dd","resolution":{"observed_at":"2026-08-06T20:14:36.442456Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2503.20913","last_updated":"2025-03-26T18:35:34Z","snapshot_observed_at":"2026-08-12T22:28:26.384537Z","submitted_at":"2025-03-26T18:35:34Z","title":"TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design","version":1},"cited_work":{"arxiv_id":"2503.20913","doi":null,"metadata_source":"pith","pith_arxiv_id":"2503.20913","snapshot_observed_at":"2026-08-06T20:14:37.184087Z","title":"TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design","venue":"cs.CE","work_id":"e4f5e18f-1b6c-48a5-943b-4d254cf89a01","year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":88,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.445381Z"},"links":{"cited_paper":"/paper/2503.20913","citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:ce88b3ad48a1efd978a674581566daee5460e87703327488a6b4977058bff9a3","observation_id":"4fa4719d-535a-4e18-8287-0596a9df2ada","resolution":{"observed_at":"2026-08-06T20:14:37.190294Z","resolver_source":"local_arxiv","status":"metadata_mismatch"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-15T06:32:42.880941+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-15T06:32:42.880941+00:00","source":"crossref"},{"observed_at":"2026-08-15T06:32:39.529945+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.448500Z","title":"Biomarker Research, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":89,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.448500Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:fe096f6528ce16344f24a0e4d9782483ac2a6bad64fbc67b9cbc811351d39f94","observation_id":"3f4321a4-6067-4a58-80cd-e192cc00bde5","resolution":{"observed_at":"2026-08-06T20:14:36.448500Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.452280Z","title":"Virtual screening: principles, challenges, and practical guidelines, 2011: p","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":90,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.452280Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:1b55bd74919a53db33f6156835c8793c44eb20e14216152b64b0a51ab7693605","observation_id":"910152ae-ddd8-4a56-81bb-8ebd7d9549af","resolution":{"observed_at":"2026-08-06T20:14:36.452280Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.455386Z","title":"Nisius, and J","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":91,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.455386Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:539727a16cf7488e0e31c476ab10a94748b06679d792b81a1f0ee08cdb1348e7","observation_id":"242b6450-3242-4402-b72c-eaf80a4f19dc","resolution":{"observed_at":"2026-08-06T20:14:36.455386Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.459425Z","title":"Scientific Reports, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":92,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.459425Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f5e0ca3665d6990196dc5ddcea55ce9e2955e90452f844cf21b7410ba6c2a3a1","observation_id":"4b752d37-86b0-4fef-a99d-f83558bbc513","resolution":{"observed_at":"2026-08-06T20:14:36.459425Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.462442Z","title":"ACS omega, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":93,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.462442Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:a900ca1eaa50ac7c66097d341e390f697c93a3cb0311bb72d2a7342a7533932c","observation_id":"19753efb-fcb7-4f97-908c-c6c038f18d62","resolution":{"observed_at":"2026-08-06T20:14:36.462442Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.465983Z","title":null,"venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":94,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.465983Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:f49e4bf03d64efa9ec01d31f9d26ff010a775d7530a5ff7d20a3ee322c7c5146","observation_id":"df3ecbc4-fe62-4038-a40f-e8ad40fd5085","resolution":{"observed_at":"2026-08-06T20:14:36.465983Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.469407Z","title":"Science of The Total Environment, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":95,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.469407Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:abaa1816e0a597ddcb65489a8803f07c55212fb082ccfcecfa809d7dc03237e1","observation_id":"37bbf6a0-b205-4e1a-994d-55377e8a797a","resolution":{"observed_at":"2026-08-06T20:14:36.469407Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.472497Z","title":"ACS omega, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":96,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.472497Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:1d10fca77aa6f06ea0711a137721686100c5616c3be44be7f55d467e28fdbf02","observation_id":"2c9e0c8e-4509-4445-b09f-1db2ff26b5e0","resolution":{"observed_at":"2026-08-06T20:14:36.472497Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.475369Z","title":"Journal of Chemical Information and Modeling, 2025","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":97,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.475369Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:dd6e44db1d4919a6d30d77a4e60342f1795b3cf58e3abbffc5729fd83b0d3f82","observation_id":"b131fcf5-1eae-4674-8c16-a24b04c8e4cf","resolution":{"observed_at":"2026-08-06T20:14:36.475369Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.478583Z","title":null,"venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":98,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.478583Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:8b1d745d283538e6770b92c2b61d8afa51c97f259422f725c2c465ae567b388b","observation_id":"2bbbb2c6-4d24-4408-8610-2bfd4671b879","resolution":{"observed_at":"2026-08-06T20:14:36.478583Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.481429Z","title":null,"venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":99,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.481429Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:74a74184f32961f7f4c0f91319ef5625dcc0661e436cea05af1aa87f0de0b279","observation_id":"67c69ea1-4388-4130-b2f4-e6fee693f4d3","resolution":{"observed_at":"2026-08-06T20:14:36.481429Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T20:14:36.484419Z","title":"Journal of Chemical Information and Modeling,","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy","version":1},"reference_index":100,"source":"pdf_text","source_observed_at":"2026-08-06T20:14:36.484419Z"},"links":{"citing_paper":"/paper/2507.03407"},"observation_digest":"sha256:4814dc4ca26bb27742c1125454b2fccda629a383a6dc2130d7deb3dba1658deb","observation_id":"224a1cfd-3094-4f61-a630-f65367cbb020","resolution":{"observed_at":"2026-08-06T20:14:36.484419Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2507.03407","last_updated":"2025-07-04T09:14:56Z","latest_version":1,"primary_category":"cs.AI","snapshot_observed_at":"2026-08-15T01:39:44.160064Z","submitted_at":"2025-07-04T09:14:56Z","title":"Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy"},"reference_resolution":{"displayed":100,"state_counts":{"malformed_identifier":0,"metadata_mismatch":2,"parse_uncertain":0,"unresolved":98,"verified_exact":0,"verified_fuzzy":0},"total_outbound_references":300},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-15T06:32:42.880941+00:00","source":"crossref"},{"observed_at":"2026-08-15T06:32:39.529945+00:00","source":"retraction_watch"}],"thesis":"As of 15 August 2026, this Paper Citation Record lists 100 of 300 outbound references and 0 inbound Pith citation observations for arXiv:2507.03407."}